en.wikipedia.org website review
Improve your SEO :: free trial!
en.wikipedia.org is 52% geoptimaliseerd!
SEO Keyword summary for en.wikipedia.org/wiki/ocrelizumab
Keywords are extracted from the main content of your website and are the primary indicator of the words this page could rank for. By frequenty count we expect your focus keyword to be ocrelizumab
Focus keyword
Short and long tail
Short Tail Keywords ocrelizumab with sclerosis |
long Tail Keywords (2 words) multiple sclerosis retrieved 25 28 march administration fda drug administration |
long Tail Keywords (3 words) retrieved 25 april food and drug drug administration fda 25 april 2020 b c d 2020 a b move to sidebar |
en.wikipedia.org On-Page SEO Scan
Descriptive Elements
The <head> element of a en.wikipedia.org/wiki/ocrelizumab page is used to inform the browser and visitors of the page about the general meta information. The head section of the page is where we place the page title, the definition of the HTML version used, the language of in which the page is written. In the head section we can also include JavaScript and CSS (markup) files for the page.
Page title
Title length
ocrelizumab wikipedia
Meta description
Meta description legth
Meta description SEO
No meta relevance in the description detected !
Content SEO
Number of Words
Spam detected?
Headings
Heading distribution
Heading normalisation
Heading SEO impact
Emphasis (bold and italic)
Emphasis SEO impact
Images
Number of images
Images dimensions
Image alt descriptions
Images SEO impact
wikipedia free encyclopedia check public domain icon wikimedia foundation powered mediawiki
Mobile SEO en.wikipedia.org/wiki/ocrelizumab
Mobile rendering
Mobile optimizations
Responsive design detected (mobile css)
No flash detected !
Mobile improvement
Marketing / lead generation for en.wikipedia.org/wiki/ocrelizumab
Social Media
Facebook shares | Facebook likes | ||
Facebook comments | Tweets | ||
Google +1 |
Conversion form
Search form
Analytics
Online presence
SERP Preview
SERP Title
SERP Link
SERP Description
Domain Level SEO
Domain name
16 characters long
Domain name SEO Impact
Path name
ocrelizumab found in path !
Structured data
Publisher Markup
Other Structured data
Website configuration
Correct processing of non-existing pages?
Favicon icon found?
Robots.txt found?
Sitemap found?
Navigation and internal links
Navigation
Url seperator
Human readable urls
Number of links
Link SEO Impact
statistics
|
en.m.wikipedia.org |
en.wikipedia.org wikimedia foundation inc
|
w view history
httpsenwikipediaorgwindexphptitleocrelizumaboldid1246306417
page information
printable version
|
wiki read
eculizumab
monoclonal
humanized
mouse
target
cd20
trade names
drugscom
medlineplus
legal status
dailymed
pregnancycategory
routes ofadministration
intravenous infusion
subcutaneous injection
l04
only
cas number
drugbank
chemspider
kegg
formula
molar mass
medication
multiple sclerosis
humanized
b cell
immunosuppressive drugs
epitope
rituximab
food and drug administration
hoffmannla roche
genentech
phase iii
firstinclass medication
indicated
intravenous infusion
hepatitis b
hives
rapid heart beating
systemic inflammatory response syndrome
rheumatoid arthritis
lupus
interferon beta1a
progressive multifocal leukoencephalopathy
b cells
antibodydependent cellmediated cytotoxicity
complementdependent cytotoxicity
the new england journal of medicine
immunogenic
clinical trials
opportunistic infections
hematological cancer
breakthrough therapy
breakthrough therapy
fast track
priority review
health canada
european medicines agency
public domain
pmid
s2cid
clinicaltrialsgov
central nervous system
signs and symptoms
ataxia
depression
diplopia
dysarthria
dysphagia
fatigue
incontinence
nystagmus
optic neuritis
pain
uhthoffs phenomenon
diagnosis of multiple sclerosis
mcdonald criteria
poser criteria
clinically isolated syndrome
expanded disability status scale
oligoclonal bands
radiologically isolated syndrome
lesional demyelinations of the central nervous system
dawsons fingers
frexalimab
management of multiple sclerosis
alemtuzumab
cladribine
dimethyl fumarate
diroximel fumarate
fingolimod
glatiramer acetate
interferon beta1b
laquinimod
mitoxantrone
monomethyl fumarate
natalizumab
hyaluronidase
ozanimod
ponesimod
siponimod
teriflunomide
daclizumab
research in multiple sclerosis
autoimmune
neuromyelitis optica spectrum disorder
diffuse myelinoclastic sclerosis
mog antibody disease
chronic inflammatory demyelinating polyneuropathy
acute disseminated encephalomyelitis
balo concentric sclerosis
marburg acute multiple sclerosis
tumefactive multiple sclerosis
experimental autoimmune encephalomyelitis
hereditary
adrenoleukodystrophy
alexander disease
canavan disease
krabbe disease
metachromatic leukodystrophy
pelizaeusmerzbacher disease
leukoencephalopathy with vanishing white matter
megalencephalic leukoencephalopathy with subcortical cysts
camfak syndrome
central pontine myelinolysis
marchiafavabignami disease
mitochondrial dna depletion syndrome
list of multiple sclerosis organizations
list of people with multiple sclerosis
multiple sclerosis drug pipeline
pathophysiology
immunosuppression
antimetabolites
purine synthesis inhibitors
azathioprine
mycophenolic acid
dihydroorotate dehydrogenase
leflunomide
antifolate
methotrexate
macrolides
il2
fkbp
cyclophilin
calcineurin
ciclosporin
pimecrolimus
tacrolimus
voclosporin
abetimus
gusperimus
lenalidomide
pomalidomide
thalidomide
pde4 inhibitor
apremilast
il1 receptor antagonists
anakinra
mtor
everolimus
ridaforolimus
sirolimus
temsirolimus
umirolimus
zotarolimus
antibodies
complement component 5
tnf inhibitor
adalimumab
afelimomab
certolizumab pegol
golimumab
infliximab
nerelimomab
interleukin
basiliximab
bimekizumab
briakinumab
brodalumab
canakinumab
guselkumab
ixekizumab
olokizumab
rilonacept
risankizumab
sarilumab
satralizumab
secukinumab
siltuximab
sirukumab
spesolimab
tildrakizumab
tocilizumab
ustekinumab
interleukin 5
mepolizumab
immunoglobulin e
omalizumab
interferon
faralimomab
il6
elsilimomab
il12
il13
il23
lebrikizumab
il17a
muromonabcd3
otelixizumab
teplizumab
visilizumab
cd4
clenoliximab
keliximab
zanolimumab
cd11a
efalizumab
cd18
erlizumab
obinutuzumab
pascolizumab
ublituximab
cd23
gomiliximab
lumiliximab
cd40
teneliximab
toralizumab
cd62llselectin
aselizumab
cd80
galiximab
cd147basigin
gavilimomab
cd154
ruplizumab
belimumab
bertilimumab
lerdelimumab
metelimumab
integrin
vedolizumab
interleukin6 receptor
odulimomab
il2 receptorcd25
inolimomab
tlymphocyte
zolimomab aritox
anifrolumab
atorolimumab
cedelizumab
emapalumab
fontolizumab
inebilizumab
maslimomab
morolimumab
ofatumumab
pexelizumab
reslizumab
rovelizumab
siplizumab
talizumab
telimomab aritox
teprotumumab
vapaliximab
vepalimomab
polyclonal
antithymocyte globulin
antilymphocyte globulin
fusion
ctla4
abatacept
belatacept
etanercept
aflibercept
alefacept
avacopan
baricitinib
blisibimod
crovalimab
danicopan
darvadstrocel
deucravacitinib
deuruxolitinib
efgartigimod alfa
hyaluronidase
etrasimod
filgotinib
iptacopan
peficitinib
pegcetacoplan
pirfenidone
ravulizumab
ritlecitinib
rozanolixizumab
sutimlimab
tofacitinib
upadacitinib
monoclonal antibodies
immune system
abrilumab
avelumab
bleselumab
camidanlumab tesirine
carlumab
cemiplimab
dupilumab
eldelumab
fresolimumab
ianalumab
lanadelumab
lenzilumab
lirentelimab
lirilumab
mavrilimumab
namilumab
oleclumab
oxelumab
pamrevlumab
placulumab
relatlimab
sifalimumab
tabalumab
tezepelumab
ulocuplumab
varlilumab
ipilimumab
durvalumab
nivolumab
tremelimumab
urelumab
nivolumabrelatlimab
chimeric
andecaliximab
priliximab
apolizumab
atezolizumab
benralizumab
camrelizumab
crizanlizumab
epratuzumab
etrolizumab
itolizumab
lampalizumab
letolizumab
ligelizumab
lulizumab pegol
mogamulizumab
ozoralizumab
pateclizumab
pembrolizumab
pidilizumab
plozalizumab
pro 140
quilizumab
retifanlimab
rontalizumab
samalizumab
spartalizumab
teclistamab
tislelizumab
tregalizumab
vatelizumab
vobarilizumab
tgn1412
dostarlimab
ibalizumab
bermekimab
brazikumab
fezakinumab
fletikumab
tralokinumab
anrukinzumab
clazakizumab
gevokizumab
mirikizumab
perakizumab
lokivetmab
lesions
besilesomab
fanolesomab
lemalesomab
sulesomab
withdrawn
|
Links to external pages
Outloing links
es.wikipedia.org
fa.wikipedia.org
fr.wikipedia.org
it.wikipedia.org
mk.wikipedia.org
or.wikipedia.org
www.wikidata.org
www.wikidata.org
www.drugs.com
www.medlineplus.gov
dailymed.nlm.nih.gov
www.whocc.no
commonchemistry.cas.org
www.drugbank.ca
precision.fda.gov
www.kegg.jp
www.drugs.com
www.guildlink.com.au
www.tga.gov.au
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.accessdata.fda.gov
finance.yahoo.com
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
eprints.soton.ac.uk
pubmed.ncbi.nlm.nih.gov
hdl.handle.net
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.reuters.com
www.medscape.com
www.clinicaltrials.gov
www.clinicaltrials.gov
foundation.wikimedia.org
foundation.wikimedia.org
foundation.wikimedia.org
www.wikimediafoundation.org
SEO Advice for en.wikipedia.org
In this section we provide pointers on how you can to optimize your web page so it can be found more easily by search engines and how to make it rank higher by optimizing the content of the page itself. For each of the individual criteria the maximum score is 100%. A score below 70% is considered to be indication that the page is not complying with general SEO standards and should be evaluated and/or fixed. Not every factor is weighted the same and some are not as important as others. Relatively unimportant factors like meta keywords are not included in the overall score.
Item | Factor | Pointers | |
---|---|---|---|
PageTitle | 100% | Far too many sites lack a page title. A page title is the first thing that shows in the search results so always use the title element. | |
Title relevance | 65% | A title should reflect the contents of a site. This site has a 50 % match | |
Title Length | 30% | Limit your title to anywhere between 40 and 70 characters. Your title was 24 characters long | |
Meta Description | 0% | A meta description is the second element that shows in the search results so always use the meta description. | |
Meta description length | 0% | The meta description should be between 145 and 160 characters. This meta description is 1 characters long. | |
Meta description relevance | 0% | Meta Description should reflect the contents of a site. This site has a 0 % match | |
Number of internal links | 30% | Linking to internal pages makes pages easier to find for search engines. Try to keep the number of links on your page roughly below 100. There are 594 internal links on this page. | |
Folder structure | 100% | We found a folder structure in the links on your page. A good folder structure makes a site easier to navigate. We found 3 level 1 folders and 9 folders above or in the first level of navigation. | |
Headings | 18% | Headers should reflect the contents of a site. This site has a 8 % match | |
Links | 8% | Link anchors should to some degree reflect the contents of a site. This site has a 4 % match | |
Image alt tags | 0% | Image alt tags should to some degree reflect the contents of a site. This site has a 0 % match | |
Bold and italic | 33% | Bold and italic tags should reflect the contents of a site to some degree. This site has a 11 % match | |
Html ratio | 30% | Try to keep the html / text ratio as low as possible. More html means longer loading times. Layout should be handled in a serpate css file | |
Image descriptions | 86% | 85.714285714286 % of all images have been described via the "alt" attribute. Describing images with relevant text may lead to better results in the search engines. | |
Page errors | 100% | Pages with no errors display significantly faster on most browsers. We detected 0 errors and warnings | |
WordCount | 20% | An ideal page contains between 400 and 600 words.This page contains 2722 words | |
Server response time | 100% | A fast server speeds up a website. This server responds 83.11% faster then average | |
Gzip compression | 30% | This site does not use Gzip compression. Pages may not display as fast as they could | |
Keywords in Domainname | 30% | There are no important keywords in your domain name | |
Keywords in domain path | 100% | There are important keywords in the domain path | |
Structured Data | 100% | Structured data makes it easier for search engines to index your website | |
Inline css | 0% | Do not use inline css declarations. Inline css will slow down the rendering of the website. We detected 168 inline style declarations ( <a style="color:green">) with a size of 2998 bytes | |
Excessive use of the same words | 100% | There is no indication that there are one or more keywords that are used excessively. | |
Frames or iframes | 100% | Perfect, detected not (i)frames on your webpagina | |
Flash | 100% | Perfect, we detected no flash objects on your page | |
Css | 30% | We detected too much (2) CSS files on your page. Css files block the loading of a webpage. | |
Javascript | 100% | Perfect, we did not detect too many blocking JavaScript files | |
Mobile Website | 100% | Perfect, we found a responsive design for mobile users | |
Most important heading | 100% | Perfect, we detected a correct use of the most important (h1) heading! | |
Normalized headings | 40% | We dit not font a normalized heading structure. A heading 2 (h2) for example should be followed by a heading of an equal level (h2), a child heading (h3) or even a aprent heading (h1). |
How would you like to have SEO advice for all your pages ?? Start your SEO Dashboard and optimize your website!
en.wikipedia.org images and descriptions
10 images found at en.wikipedia.org Images can improve the user experience for a website by making a pag visually appealing Images can also add extra keyword relevance to a webpage by using alt tags. Images can also slow down a website. If the width and height for a picture is not specified for a browser know in advance how large the image is. A browser must first load the picture and see before it knows how much space should be on the page. Upon reservation In the meantime, the browser can do little but wait. When the height and width for the plate are given in the HTML code, a browser just continues to build for a page while the images load in the background.
http://en.wikipedia.org/static/images/icons/wikipedia.png height: 50 width: 50 description: no alt description found |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-wordmark-en.svg height: height attribute not set width: width attribute not set description: wikipedia |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-tagline-en.svg height: 13 width: 117 description: the free encyclopedia |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/x_mark.svg/7px-x_mark.svg.png height: 8 width: 7 description: ☒ |
|
https://upload.wikimedia.org/wikipedia/en/thumb/f/fb/yes_check.svg/7px-yes_check.svg.png height: 7 width: 7 description: check |
|
https://upload.wikimedia.org/wikipedia/en/thumb/6/62/pd-icon.svg/12px-pd-icon.svg.png height: 12 width: 12 description: public domain |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/who_rod.svg/8px-who_rod.svg.png height: 19 width: 8 description: icon |
|
https://login.wikimedia.org/wiki/special:centralautologin/start?type=1x1 height: 1 width: 1 description: no alt description found |
|
http://en.wikipedia.org/static/images/footer/wikimedia-button.svg height: 29 width: 84 description: wikimedia foundation |
|
http://en.wikipedia.org/w/resources/assets/poweredby_mediawiki.svg height: 31 width: 88 description: powered by mediawiki |
How are images contributing to your SEO site-wise ? Your leading content tool has the awnsers!